ZNTL
#3225
Zentalis Pharmaceuticals, Inc. - common stock
4.7 7 USD
+0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.25%
Monthly Change
+26.86%
6 month change
+50.95%
Year Change
+253.33%
Previous Close
4.6 2
Open
4.7 7
Low
4.7 7
High
4.7 7
Volume
31
Financials
- Market Capitalization 339.56 M
- Employee 106
- Founded 2014
- CEO N/A
- Website www.zentalis.com
- Headquarter California, United States
- FIGI BBG00R2K8TF5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.71
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3210 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.99 USD | -0.99% | +2.40% | +47.29% | +162.28% | 348.51 M USD | ||
| 3217 |  HELP Cybin Inc. - Common Stock | 6.68 USD | -0.30% | +13.03% | +56.81% | -25.53% | 344.90 M USD | ||
| 3229 |  IMRX Immuneering Corporation - Class A Common Stock | 5.21 USD | +0.97% | +0.97% | +24.34% | +28.33% | 337.07 M USD | ||
| 3230 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.57 USD | -0.34% | -0.27% | +15.00% | -4.58% | 336.55 M USD |
Frequently asked questions about Zentalis Pharmaceuticals, Inc. - common stock
What is the Zentalis Pharmaceuticals, Inc. - common stock stock price today?
The current price of Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) is 4.77. Over the past 24 hours, the stock has changed by +3.25%. Follow the ZNTL chart for real-time price dynamics.
What is the stock ticker of Zentalis Pharmaceuticals, Inc. - common stock?
Zentalis Pharmaceuticals, Inc. - common stock trades under the ticker ZNTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zentalis Pharmaceuticals, Inc. - common stock stock going up?
ZNTL has changed by 0.00% over the last week, +26.86% over the last month, and +253.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Zentalis Pharmaceuticals, Inc. - common stock net income for the last quarter?
Zentalis Pharmaceuticals, Inc. - common stock reported net income of -35.35 M for the last quarter. The previous quarter showed -35.22 M, which means net income changed by -0.39%.
How many employees does Zentalis Pharmaceuticals, Inc. - common stock have?
As of the latest available data, Zentalis Pharmaceuticals, Inc. - common stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zentalis Pharmaceuticals, Inc. - common stock EBITDA?
Zentalis Pharmaceuticals, Inc. - common stock EBITDA is -37.3 M, and its EBITDA margin is -9 326%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zentalis Pharmaceuticals, Inc. - common stock stock?
You can buy Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zentalis Pharmaceuticals, Inc. - common stock stock?
Investing in Zentalis Pharmaceuticals, Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZNTL chart and related analysis on metatrader.com as part of your research.